Cargando…

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia

Despite advances in the understanding of the genetic landscape of acute myeloid leukemia (AML) and the addition of targeted biological and epigenetic therapies to the available armamentarium, achieving long-term disease-free survival remains an unmet need. Building on growing knowledge of the intera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasvolsky, Oren, Daher, May, Alatrash, Gheath, Marin, David, Daver, Naval, Ravandi, Farhad, Rezvani, Katy, Shpall, Elizabeth, Kebriaei, Partow
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784883/ https://www.ncbi.nlm.nih.gov/pubmed/35083154 http://dx.doi.org/10.3389/fonc.2021.800110

Ejemplares similares

Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future
por: Sanchez-Petitto, Gabriela, et al.
Publicado: (2023)

FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
por: Daver, Naval, et al.
Publicado: (2021)

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead
por: Pasvolsky, Oren, et al.
Publicado: (2023)

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
por: Popat, Uday R., et al.
Publicado: (2023)

Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
por: Short, Nicholas J., et al.
Publicado: (2019)

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
por: Short, Nicholas J., et al.
Publicado: (2023)

Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
por: Reville, Patrick K., et al.
Publicado: (2021)

Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient Selection
por: Abbas, Hussein A, et al.
Publicado: (2019)

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
por: Bashir, Qaiser, et al.
Publicado: (2022)

P500: SUPERIOR OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AMONG PATIENTS ≥ 60 YEARS TREATED WITH CLADRIBINE, LOW DOSE CYTARABINE PLUS VENETOCLAX FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
por: Senapati, Jayastu, et al.
Publicado: (2023)

Sarah Gilbert: carving a path towards a COVID-19 vaccine
por: Lane, Richard
Publicado: (2020)

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
por: Strati, Paolo, et al.
Publicado: (2023)

Carving of Block-Teeth
por: Coney, F. A.
Publicado: (1895)

Carving of Block-Teeth
por: Coney, F. A.
Publicado: (1895)

Targeting PR1 in myeloid leukemia
por: Alatrash, Gheath, et al.
Publicado: (2017)

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
por: Saberian, Chantal, et al.
Publicado: (2021)

Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant
por: Nieto, Yago, et al.
Publicado: (2023)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
por: Greenbaum, Uri, et al.
Publicado: (2020)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Resistance to targeted therapies: delving into FLT3 and IDH
por: Desikan, Sai Prasad, et al.
Publicado: (2022)

CAR‐NK cells: the next wave of cellular therapy for cancer
por: Daher, May, et al.
Publicado: (2021)

Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021)

Bubble chamber tracks carved on glass
Publicado: (1977)

Carving out gravitational theory space
por: Simmons-Duffin, David
Publicado: (2022)

The Invisibility of Scotomas I: The Carving Hypothesis
por: Peli, Eli, et al.
Publicado: (2023)

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
por: Singh, Harjeet, et al.
Publicado: (2022)

Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits
por: Smith, Julia J., et al.
Publicado: (2020)

P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
por: Popat, Uday R., et al.
Publicado: (2023)

Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?
por: Swaminathan, Mahesh, et al.
Publicado: (2023)

Carving out the Swampland of 6D SCFTs
por: Baume, Florent
Publicado: (2019)

The olmec rock carving at Xoc, Chiapas, Mexico
por: Ekholm-Miller, Susanna
Publicado: (1973)

Protein–Protein Interaction Hotspots Carved into Sequences
por: Ofran, Yanay, et al.
Publicado: (2007)

Chemical carving lithography with scanning catalytic probes
por: Ki, Bugeun, et al.
Publicado: (2020)

African cratonic lithosphere carved by mantle plumes
por: Celli, Nicolas Luca, et al.
Publicado: (2020)

CARving up colorectal cancer organoids in vitro
por: Schürch, Christian M.
Publicado: (2019)

Carving a niche for immunotherapy in ovarian cancer
por: Gupta, Nitasha, et al.
Publicado: (2021)

Spontaneous Afferent Activity Carves Olfactory Circuits
por: Redolfi, Nelly, et al.
Publicado: (2021)

Root carving in tooth morphology – Is it really necessary?
por: Sivapathasundharam, B, et al.
Publicado: (2021)

The Art of Carving and Baking Porcelain Teeth and Crowns
por: Moffatt, R. T.
Publicado: (1904)

Cannot write session to /tmp/vufind_sessions/sess_ep8s9ortt7vft3i2354g8gjr3i